Latest Articles
N.S. woman with endometriosis had to seek surgical care in U.S. - Global News
N.S. woman with endometriosis had to seek surgical care in U.S. Global News
Published: Nov. 13, 2025, 2:02 p.m.
Insufficient Endometrial Biopsy Increases Cancer Risk - European Medical Journal
Insufficient Endometrial Biopsy Increases Cancer Risk European Medical Journal
Published: Nov. 13, 2025, 1:03 p.m.
Rollout of clinics to treat endometriosis - The Australian
Rollout of clinics to treat endometriosis The Australian
Published: Nov. 13, 2025, 1:01 p.m.
Unheard. Unserved: After Costly U.s. Surgery, Endometriosis Patient Pushes For More Options - beritaja.com
Unheard. Unserved: After Costly U.s. Surgery, Endometriosis Patient Pushes For More Options beritaja.com
Published: Nov. 13, 2025, 11:09 a.m.
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - unpublished.ca
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options unpublished.ca
Published: Nov. 13, 2025, 11:05 a.m.
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - Unpublished Media
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options Unpublished Media
Published: Nov. 13, 2025, 11:05 a.m.
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - Global News
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options Global News
Published: Nov. 13, 2025, 11 a.m.
MAMAVISION | Gabriela Kocev: I became a mother with a bicornuate uterus and endometriosis, the doctors called me a phenomenon - Слободен печат
MAMAVISION | Gabriela Kocev: I became a mother with a bicornuate uterus and endometriosis, the doctors called me a phenomenon Слободен печат
Published: Nov. 13, 2025, 10:57 a.m.
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare
Published: Nov. 13, 2025, 6:17 a.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어
Published: Nov. 13, 2025, 5:50 a.m.
Link copied to clipboard!